A Randomized Study of Sulindac in Oral Premalignant Lesions

Clinical trial NCT00299195 · COMPLETED

Trial details

NCT number: NCT00299195
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Leukoplakia, Oral Benign Neoplasms

Start date: 2006-02-23
Primary completion: 2020-01-06
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.